ATAI Life Sciences Announces Closing of $125 Million Series C Financing Round

With ATAI eying a Spring 2021 IPO, it announces a $125 million private equity financing for Series C.

Read more
Novamind Closes Oversubscribed CAD$10 Million Private Placement

Novamind has closed on double its original target (CAD$5 million). Preparing to commence trading on the CSE (symbol “NM”).

Read more
Why An ATAI IPO Is Driving MindMed Stock

ATAI Life Sciences is going public. MindMed Inc is hitting new highs. The two events ARE connected.

Read more

MindMed launches its digital medical division.

Read more
Entheon Biomedical to Begin Trading on the Frankfurt Exchange

Entheon adds a German listing to its original CSE listing.

Read more
The Psychedelics Revolution: It’s No Longer BAD To Feel GOOD

A Psychedelic Drug Revolution is occurring — to bring badly needed psychedelic medicines to a world suffering from a Mental Health Crisis.

Read more
MindMed Announces 2nd $25 Million Bought Deal Public Offering

MindMed’s most recent financing is at nearly double where it priced units just 6 weeks earlier.

Read more
MindMed Upsizes Previously Announced Bought Deal Public Offering

MindMed’s CAD$25-million bought deal financing becomes a $30 million financing — the same day.

Read more
New York Marijuana Legalization Support Is Higher Now Than Ever Before, Poll Finds

New York voters support legalizing marijuana by a nearly two-to-one ratio, according to a new poll released on Tuesday.

Read more
Election underscores voter shift in favor of marijuana legalization

An analysis of votes cast for marijuana ballot measures in 2020 shows that while voters remain divided over legalization based on political affiliation and geography, the overall electorate has shifted in favor of accepting both medical and adult-use cannabis.

Read more



( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )